A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

153 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-14

Study Completion Date

2025-08-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants

NCT01878331

Jaw, Edentulous

COMPLETED

Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants

NCT05768295

Surgical Operation Edentulous Jaw Edentulous Mouth +1 more

ACTIVE_NOT_RECRUITING NA

DEntal implaNt Set: Development and Implementation of a Standardized Outcome Set in Implant Dentistry

NCT07337057

Tooth Loss / Rehabilitation

RECRUITING

Immediate Loading of Implants in the Partially or Completely Edentulous Jaw

NCT02661412

Jaw, Edentulous, Partially Jaw, Edentulous

ACTIVE_NOT_RECRUITING

Immediate Versus Late Placement

NCT04741607

Esthetics

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Operation With Implant of Artificial Internal Device

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgical placement of an endosteal implant

Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients seeking an implant supported restoration
* all patients with conditions that are in accordance with the IFU
* Patients must provide their informed consent for study participation and must be willing and able to attend control visits
* Patients need to be at least 18 years old